Multiple diaphyseal sclerosis (Ribbing disease): what about neridronate?

We report the case of a patient that showed lack of response to intravenous neridronate within 1  year of treatment, both in terms of pain and persistence of bone marrow edema at MRI.
Source: Osteoporosis International - Category: Orthopaedics Source Type: research